Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,294 | -7,434 | -39,261 | -29,906 | -18,560 |
| Accounts payable and accrued liabilities | 844 | 1,871 | 329 | 1,758 | -872 |
| Other Working Capital | -4,980 | -4,205 | 7,284 | 7,129 | 2,174 |
| Other Operating Activity | -773 | -1,958 | 3,324 | 1,571 | 3,989 |
| Operating Cash Flow | $-20,202 | $-11,726 | $-28,324 | $-19,448 | $-13,269 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 415 | 415 | 668 | 668 | 668 |
| Common Stock Issued | 2,805 | N/A | 33,172 | 5,678 | 5,678 |
| Other Financing Activity | -208 | -83 | -668 | -445 | -445 |
| Financing Cash Flow | $3,013 | $332 | $33,172 | $5,900 | $5,900 |
| Beginning Cash Position | 23,368 | 23,368 | 18,520 | 18,520 | 18,520 |
| End Cash Position | 6,178 | 11,974 | 23,368 | 4,972 | 11,152 |
| Net Cash Flow | $-17,189 | $-11,394 | $4,848 | $-13,548 | $-7,368 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,202 | -11,726 | -28,324 | -19,448 | -13,269 |
| Free Cash Flow | -20,202 | -11,726 | -28,324 | -19,448 | -13,269 |